Diagnostics for the Real World (DRW)

medical devices

About

Diagnostics for the Real World (DRW) is a biotechnology company founded in 2003, originating from the University of Cambridge. The company focuses on developing and commercializing innovative diagnostic technologies tailored for resource-limited and real-world clinical settings, particularly in developing countries. DRW specializes in point-of-care molecular diagnostics, enabling rapid and reliable testing of infectious diseases directly at the site of patient care. Its flagship technology, the SAMBA platform, is designed for challenging environments, requiring no complex laboratory infrastructure. The company offers a range of products, including rapid tests for Chlamydia and HIV, as well as multiplex respiratory virus tests that detect multiple pathogens from a single sample. DRW collaborates with international organizations to implement its technologies, aiming to improve healthcare outcomes in areas with limited access to diagnostic resources.

Technologies

Outlook Google Cloud Hosting WordPress.org Google Tag Manager Google Maps (Non Paid Users) Mobile Friendly Google Maps Nginx Vimeo

Keywords

diagnostics molecular diagnostics point of care medical device medical technology infectious diseases multiplex respiratory virus tests point-of-care molecular assays medical equipment and supplies manufacturing covid-19 diagnostics sample-in to result automation easy to use diagnostics hepatitis b and c tests laboratory automation high performance diagnostics influenza a/b detection cold chain free reagents samba platform hiv diagnostics connectivity and data management clinical intervention support clinical validation hiv viral load testing assay development pcr-like performance medical devices resource-limited healthcare rapid testing global health diagnostics gonorrhea and chlamydia duplex tests

Location

Chesterford Research Park, Saffron Walden, England, United Kingdom, CB10 1XJ

Related Companies

Companies in the same industry